BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 31

• Press Releases

  The ADDF Highlights Encouraging Progress Toward Targeting Multiple Alzheimer’s Pathologies in Biogen’s Phase 2 Tau Study

  May 14, 2026

   · 

  3 min read
• Press Releases

  Gilead Prices $3 Billion of Senior Unsecured Notes

  May 14, 2026

   · 

  3 min read
• Press Releases

  Imperative Care Appoints Jay Martin as Chief Commercial Officer

  May 14, 2026

   · 

  3 min read
• Press Releases

  Myomo Announces Participation in Upcoming May 2026 Investor Conferences

  May 14, 2026

   · 

  1 min read
• Press Releases

  SN BioScience Doses First Patient in Phase 1b/2 Clinical Trial of ‘SNB-101'

  May 14, 2026

   · 

  2 min read
• Press Releases

  Personalis to Participate in Upcoming Investor Events

  May 14, 2026

   · 

  1 min read
• Press Releases

  Sharps Technology Adopts Limited Duration Stockholder Rights Plan

  May 14, 2026

   · 

  4 min read
• Press Releases

  Menarini Group Announces New Data at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting

  May 14, 2026

   · 

  20 min read
• Press Releases

  BeOne Medicines’ BEQALZI™ (sonrotoclax) Approved by U.S. FDA as First and Only BCL2 Inhibitor for R/R Mantle Cell Lymphoma

  May 14, 2026

   · 

  10 min read
• Press Releases

  U.S. FDA Approves INQOVI® in Combination with Venetoclax, the First All-Oral Combination Treatment for Patients with Acute Myeloid Leukemia Who Are Ineligible for Intensive Induction Chemotherapy

  May 14, 2026

   · 

  12 min read